Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2014

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

(In thousands)	Fiscal Year Ended June 30,
Medical Indication	2014		2013		2012
Antibiotic	$	13,572	$	9,167	$	6,724
Cardiovascular	62,121		25,876		18,142
Gallstone	6,578		6,114		5,991
Glaucoma	11,987		6,410		4,252
Gout	10,822		5,092		484
Migraine	14,527		5,418		5,971
Obesity	4,032		4,721		3,755
Pain Management	27,174		21,232		20,870
Thyroid Deficiency	102,248		57,978		50,849
Other	20,710		9,046		5,952
Total	$	273,771	$	151,054	$	122,990

Summary of products which accounted for at least 10% of net sales

	June 30,2014		June 30,2013		June 30,2012
Product 1	37	%	38	%	41	%
Product 2	20	%	8	%	9	%
Product 3	8	%	10	%	8	%

Summary of customers which accounted for at least 10% of net sales

	June 30,2014		June 30,2013		June 30,2012
Customer A	19	%	12	%	11	%
Customer B	13	%	17	%	18	%
Customer C	9	%	10	%	12	%